(±)14-HDHA (Synonyms: 14hydroxy Docosahexaenoic Acid, (±)14-HDoHE) |
Catalog No.GC41193 |
(±)14-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 87042-40-8
Sample solution is provided at 25 µL, 10mM.
(±)14-HDHA is an autoxidation product of docosahexaenoic acid (DHA) in vitro. It is also produced from incubations of DHA in rat liver, brain, and intestinal microsomes. DHA is metabolized to 14(S)-HDHA by human platelets along with 11(S)-HDHA. 14(S)-HDoHE is also produced by salmon gills upon stimulation with calcium ionophore. 14(S)-HDHA was shown to be an inhibitor of U-46619-induced human platelet aggregation and rabbit and rat aortic smooth muscle contraction with IC50 values of about 70, 3.6, and 5.3 µM, respectively. (±)14-HDHA is a potential marker of oxidative stress in brain and retina where DHA is an abundant polyunsaturated fatty acid.
Average Rating: 5
(Based on Reviews and 2 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *